scholarly journals A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus

2006 ◽  
Vol 13 (1) ◽  
pp. 40-51 ◽  
Author(s):  
S. Shea ◽  
R. S. Weinstock ◽  
J. Starren ◽  
J. Teresi ◽  
W. Palmas ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Case Management ◽  
Usual Care ◽  
Randomized Trial ◽  
Ethnically Diverse ◽  
Medically Underserved ◽  
Underserved Patients ◽  
Patients With Diabetes

scholarly journals The Effects of Glucose Load on Catabolism during Remifentanil-Based Anesthesia in Patients with Diabetes Mellitus: A Prospective Randomized Trial

2015 ◽  
Vol 05 (07) ◽  
pp. 155-162 ◽  
Author(s):  
Maiko Hasegawa-Moriyama ◽  
Mayumi Nakahara ◽  
Takayuki Saito ◽  
Tomotsugu Yamada ◽  
Keika Mukaihara ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Randomized Trial ◽  
Prospective Randomized Trial ◽  
Glucose Load ◽  
Patients With Diabetes

scholarly journals A Randomized Trial Comparing Intensive and Passive Education in Patients With Diabetes Mellitus

2002 ◽  
Vol 162 (11) ◽  
pp. 1301 ◽  
Author(s):  
Annaswamy Raji ◽  
Helen Gomes ◽  
Judith O. Beard ◽  
Patricia MacDonald ◽  
Paul R. Conlin
Keyword(s):  
Diabetes Mellitus ◽  
Randomized Trial ◽  
Patients With Diabetes ◽  
Passive Education

Recruitment and Enrollment of Rural and Urban Medically Underserved Elderly into a Randomized Trial of Telemedicine Case Management for Diabetes Care

2006 ◽  
Vol 12 (5) ◽  
pp. 601-607 ◽  
Author(s):  
Walter Palmas ◽  
Jeanne Teresi ◽  
Philip Morin ◽  
L. Thomas Wolff ◽  
Lesley Field ◽  
...  
Keyword(s):  
Case Management ◽  
Randomized Trial ◽  
Diabetes Care ◽  
Medically Underserved ◽  
Rural And Urban

scholarly journals ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN

2018 ◽  
pp. 68-74
Author(s):  
Alexey D. Ehrlich
Keyword(s):  
Diabetes Mellitus ◽  
Atrial Fibrillation ◽  
Randomized Trial ◽  
Oral Anticoagulant ◽  
Observational Studies ◽  
Theoretical Data ◽  
Comparative Efficacy ◽  
Systemic Embolism ◽  
Actual Clinical Practice ◽  
Patients With Diabetes

The presented material summarizes the main clinical and theoretical data on the peculiarities of atrial fibrillation (AP) flow in combination with diabetes mellitus (DM). This combination, although associated with a lower age than in patients without diabetes, is associated with a higher risk of stroke and systemic embolism and other adverse complications. The material presents the data of the rocket-AF randomized trial subanalysis on the peculiarities of the use of oral anticoagulant - a direct inhibitor of Xa-factor Rivaroxaban in patients with non-valve AF in combination with DM. Comparative efficacy and safety of Rivaroxaban in patients with diabetes were comparable to those in patients without diabetes. Rivaroxaban in patients with diabetes was associated with lower vascular death rates than warfarin. The results of the randomized trial are largely confirmed in several observational studies that reflect actual clinical practice. Thus, it can be affirmed that Rivaroxaban is not only the most commonly used direct oral anticoagulant in russian practice, but can also be widely used in patients with non-valve AF and diabetes to prevent strokes and systemic embolisms.

Sign in / Sign up

Export Citation Format

Share Document